Regarding IL-10 levels in premalignant and malignant CR lesions, double immunohistochemistry revealed more abundant CD4/CD25 and IL-10/FoxP3 dual-positive Tregs within the tumor stroma in both adenomas and carcinomas [57]. This evidence concerns the gene IL10 and carcinoma.